This retrospective study shows that among nearly 160,000 patients with pulmonary hypertension (PH), those who also had gastroesophageal reflux disease (GERD) had lower rates of morbidity and mortality.
Patients with gastroesophageal reflux disease (GERD) may have more favorable pulmonary hypertension (PH) outcomes, say the researchers of a new study, who suggest that the findings may be due to GERD treatment having benefits for lung disease.
The retrospective study, published in Cureus, showed that among nearly 160,000 patients with PH, those who also had GERD had lower rates of morbidity and mortality. The overall mortality rate between 2001 and 2013 was 3.57% among patients with GERD compared with 4.56% among patients without esophageal reflux. The former group of patients also had significantly shorter hospital stays than patients with PH alone.
Gastroesophageal reflux disease (GERD) or acid reflux symptoms: © Orawan - stock.adobe.com
“We hypothesize that this difference may again be attributed to the use of PPIs [proton pump inhibitors]. Debilitated or severely ill patients often have increased micro-aspirations leading to macro-aspirations and pneumonia, among other pathologies, thereby prolonging hospital stays,” described the group. “By reducing the acidity of these aspirations, acid-modulating medications may protect patients with GERD from exacerbations of their PH and reduce their hospital stay. Thus, the diagnosis of GERD may counterintuitively have a protective role because of PPI treatment.”
Although primary causes of PH are relatively well characterized, secondary causes remain less known and include the association between PH and GERD. It’s hypothesized that micro-aspirations associated with reflux lead to erosion and damage of the lung parenchyma, thus eliciting the development of interstitial lung disease.
The findings from the retrospective study translated into lower hospital costs for the group of patients with PH and GERD, found the researchers. Although costs increased significantly across the board throughout the study period, patients with the comorbidities had significantly lower costs.
Looking at other comorbidities, the researchers found that a codiagnosis with GERD was associated with a higher likelihood of acute heart failure exacerbations and aspiration pneumonia but was associated with a lower likelihood of myocardial infarctions, cardiac arrests, pulmonary embolism, pulmonary hemorrhages, cardiac interventions, acute respiratory failure, acute renal failure, and urinary tract infections.
These patients were more likely to have a variety of other comorbidities, including obesity.
“Obesity is also known to be associated with an increased risk of GERD; studies have found the incidence of GERD in the United States to be 18.1% to 27.8% with an [odds ratio] of 1.58 of having GERD in obese people,” detailed the researchers.” Patients with GERD and PH are likely to have increased adiposity. These factors may lead to increased chronic cardiac stress resulting in worsening heart failure. While the use of PPIs might have a cardioprotective role (as demonstrated by the decreased risk of myocardial infarction and cardiac arrest), obesity may worsen heart disease. This may explain that while our patients with GERD had a trend (nonsignificant) toward a decreased risk of acute heart failure exacerbation, their weight may have an inverse effect by worsening heart failure.”
Reference
Mittal A, Hossain A, Wang D, et al. Role of gastroesophageal reflux disease in morbidity and mortality for patients admitted with pulmonary hypertension. Cureus. Published online May 24, 2023. doi:10.7759/cureus.39431
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Study Validates Smartphone Analysis for Predicting Obstructive Sleep Apnea
November 29th 2023Findings show breathing sounds recorded by smartphones during sleep at home can reliably identify obstructive sleep apnea, presenting an innovative and accessible alternative to traditional in-laboratory polysomnography.
Read More